Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Biochemical Journal|January 15, 2011
The diverse members of the mammalian HSP70 machine show distinct chaperone-like activitiesJurre Hageman, Maria A W H van Waarde, Alicja Zylicz, et al.
The Journal of Biological Chemistry|August 7, 2010
ATP binding to Hsp90 is sufficient for effective chaperoning of p53 proteinDawid Walerych, Malgorzata Gutkowska, Marcin P Klejman, et al.
Biological Chemistry|October 7, 2005
Psc3 cohesin of Schizosaccharomyces pombe: cell cycle analysis and identification of three distinct isoformsEduard Ilyushik, David W Pryce, Dawid Walerych, et al.
Molecular Cancer|June 17, 2010
The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatinVeronika Kvardova, Roman Hrstka, Dawid Walerych, et al.
Oncoimmunology|September 19, 2017
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1Anna Tosi, Silvia Dalla Santa, Elisa Cappuzzello, et al.
The Journal of Biological Chemistry|September 11, 2004
Hsp90 chaperones wild-type p53 tumor suppressor proteinDawid Walerych, Grzegorz Kudla, Malgorzata Gutkowska, et al.
Molecular Oncology|June 5, 2026
Patient therapy outcome modeling in cancer organoids is improved by cancer-associated fibroblasts and organoid assembly convolutionMarcin Grochowski, Liudmyla Dolinchuk, Michał Jerzak, et al.
Cell Death & Disease|August 31, 2024
A common druggable signature of oncogenic c-Myc, mutant KRAS and mutant p53 reveals functional redundancy and competition among oncogenes in cancerMaria Grześ, Akanksha Jaiswar, Marcin Grochowski, et al.
Cell Reports|September 28, 2022
The molecular network of the proteasome machinery inhibition response is orchestrated by HSP70, revealing vulnerabilities in cancer cellsMagdalena Oroń, Marcin Grochowski, Akanksha Jaiswar, et al.
Nature Cell Biology|June 28, 2016
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancerDawid Walerych, Kamil Lisek, Roberta Sommaggio, et al.
Pageof 2